FYARRO (Sirolimus)

**Product type:** Human Prescription Drug

**Active ingredient:** SIROLIMUS

**Strength:** 5 mg/mL

**Dosage form:** Injection, Powder, Lyophilized, For Suspension

**Route:** Intravenous

**Labeler:** Aadi Bioscience, Inc.

**Marketing category:** NDA (NDA213312)

**Pharmacologic class:** Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]